AP21155692599756-640×400.jpg

This image provided by Novo Nordisk on Friday, June 4, 2021 shows a package of injection pens for the company’s semaglutide medication, named Wegovy. On Friday, the Food and Drug Administration said this new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S. (Novo Nordisk via AP)